Clinical benefit of bone-targeted radiometabolic therapy with 153Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancer

Author: Ricci Sergio   Boni Giuseppe   Pastina Ilaria   Genovesi Dario   Cianci Claudia   Chiacchio Serena   Orlandini Cinzia   Grosso Mariano   AlSharif Abedallatif   Chioni Aldo   Donato Samantha   Francesca Francesco   Selli Cesare   Rubello Domenico   Mariani Giuliano  

Publisher: Springer Publishing Company

ISSN: 1619-7070

Source: European Journal of Nuclear Medicine and Molecular Imaging, Vol.34, Iss.7, 2007-07, pp. : 1023-1030

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content